Experimental COVID-19 vaccine shows promise in early-stage study

Reuters|
PrintFind an error? Report us
Moderna Inc said on Monday its experimental vaccine for COVID-19 showed promise in early trials and it looks to advance the vaccine into late-stage trials in July.
The vaccine, mRNA-1273, was also found to be generally safe and well-tolerated in the early-stage study, the drug developer said.
Comments
The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.
""